C Gerlinger
Overview
Explore the profile of C Gerlinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Gaspard U, Endrikat J, Desager J, Buicu C, Gerlinger C, Heithecker R
Contraception
. 2004 Mar;
69(4):271-8.
PMID: 15033400
In this open-label, randomized study we compared the influence of a new oral contraceptive containing 30 microg ethinylestradiol and 3 mg drospirenone (EE + DRSP = Yasmin), with a reference...
12.
Endrikat J, Mih E, Dusterberg B, Land K, Gerlinger C, Schmidt W, et al.
Contraception
. 2004 Feb;
69(3):179-87.
PMID: 14969664
In this first prospective, double-blind, randomized, parallel-group study we evaluated the influence of two combined oral contraceptives on bone mineral density (BMD) and metabolic bone parameters. One dose-reduced preparation contained...
13.
Gerlinger C, Endrikat J, van der Meulen E, Dieben T, Dusterberg B
Eur J Contracept Reprod Health Care
. 2003 Jul;
8(2):87-92.
PMID: 12836662
A new guideline on the clinical investigation of steroid contraceptives in women, which has been released by the European Agency for the Evaluation of Medicinal Products (EMEA), calls for the...
14.
Gaspard U, Scheen A, Endrikat J, Buicu C, Lefebvre P, Gerlinger C, et al.
Contraception
. 2003 Jun;
67(6):423-9.
PMID: 12814810
In this open-label, randomized study we compared the influence of a new oral contraceptive containing 30 microg ethinylestradiol and 3 mg drospirenone (Yasmin) with a reference preparation containing 30 microg...
15.
Endrikat J, Gerlinger C, Plettig K, Wessel J, Schmidt W, Grubb G, et al.
Gynecol Endocrinol
. 2003 May;
17(2):107-14.
PMID: 12737671
We aimed to evaluate potential correlation between ovarian activity during use of combined oral contraceptives and the incidence of intermenstrual bleeding. Data from seven prospective clinical studies with five different...
16.
Endrikat J, Blode H, Gerlinger C, Rosenbaum P, Kuhnz W
Eur J Contracept Reprod Health Care
. 2002 Aug;
7(2):79-90.
PMID: 12201326
This study investigated the pharmacokinetics of a dose-reduced oral contraceptive containing 20 microg ethinylestradiol (EE) + 100 microg levonorgestrel (LNG) in 18 young, healthy females. Serum levels of EE and...
17.
Endrikat J, Klipping C, Cronin M, Gerlinger C, Ruebig A, Schmidt W, et al.
Contraception
. 2002 Apr;
65(3):215-21.
PMID: 11929643
In this open label, randomized study we compared the influence of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol (EE) and 100 microg levonorgestrel (20 EE) with a reference...
18.
Endrikat J, Gerlinger C, Cronin M, Wessel J, Ruebig A, Rosenbaum P, et al.
Eur J Contracept Reprod Health Care
. 2002 Feb;
6(4):199-204.
PMID: 11848649
Objectives: Evaluation of the impact of an oral contraceptive on body weight with a comparison ofwomen who completed versus women who prematurely discontinued intake. Methods: Data on body weight were...
19.
Endrikat J, Gerlinger C, Cronin M, Ruebig A, Schmidt W, Dusterberg B
Eur J Contracept Reprod Health Care
. 2002 Jan;
6(3):159-66.
PMID: 11763980
Objectives: Evaluation of the impact of a monophasic gestodene-based oral contraceptive on blood pressure in a population that was normotensive at baseline. Methods: Data on blood pressure were retrospectively analyzed...
20.
Endrikat J, Klipping C, Gerlinger C, Ruebig A, Schmidt W, Holler T, et al.
Contraception
. 2001 Dec;
64(4):235-41.
PMID: 11747873
In this double-blind study we compared the influence of two oral contraceptives, a 23-day regimen with 20 microg ethinyl estradiol and 75 microg gestodene (23-day 20/75) and a 21-day regimen...